Meibang Co., Ltd. (605033.SH) announced a dividend of 0.045 yuan per share for the first three quarters, with the equity registration date on December 18.

Meibang Co., Ltd. (605033.SH) announced that the company will implement equity distribution for the first three quarters of 2024, with a dividend per share ...

Zhitong FinanceDec 11 16:25

Shaanxi Meibang Pharmaceutical Group to Terminate Bond Issue

MT NewswiresNov 14 16:37

Meibang Shares (605033.SH): Terminate the issuance of convertible bonds to unspecified persons and withdraw the application documents.

Gelonghui November 13th | Meiban Shares (605033.SH) announced that since the company applied to issue convertible corporate bonds to unspecified entities, the company has been actively advancing related work with relevant institutions. However, considering factors such as operational performance and market environment, the company has communicated repeatedly with various institutions and decided to terminate the issuance of convertible corporate bonds to unspecified entities.

Gelonghui FinanceNov 13 16:18

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 30 00:00 · Announcements

Announcement of major operating data for the third quarter of 2024 of Shaanxi Meibang Pharmaceutical Group Co., Ltd.

SZSIOct 30 00:00 · Announcements

Meibang Shares (605033.SH): net income in the first three quarters was 43.276 million yuan, a year-on-year decrease of 38.34%.

GeLongHui on October 29th: Meibang Stock(605033.SH) released its third-quarter report, with a revenue of 0.62 billion yuan in the first three quarters, a year-on-year increase of 12.49%, a net income of 43.276 million yuan, a year-on-year decrease of 38.34%, a non-net profit of 31.37 million yuan, a year-on-year decrease of 52.62%, and an EPS of 0.32 yuan.

Gelonghui FinanceOct 29 20:12